GB1461240A - Cycloaliphatic derivatives of 3,3-diphenyl-propylamine - Google Patents

Cycloaliphatic derivatives of 3,3-diphenyl-propylamine

Info

Publication number
GB1461240A
GB1461240A GB2041575A GB2041575A GB1461240A GB 1461240 A GB1461240 A GB 1461240A GB 2041575 A GB2041575 A GB 2041575A GB 2041575 A GB2041575 A GB 2041575A GB 1461240 A GB1461240 A GB 1461240A
Authority
GB
United Kingdom
Prior art keywords
formula
carbon atoms
reaction
compound
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2041575A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maggioni and C SpA
Original Assignee
Maggioni and C SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maggioni and C SpA filed Critical Maggioni and C SpA
Publication of GB1461240A publication Critical patent/GB1461240A/en
Expired legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1461240 3,3-Diphenylpropylamine derivatives MAGGIONI & C SpA 14 May 1975 [15 May 1974] 20415/75 Heading C2C Novel compounds of Formula I wherein X is lower alkyl; R is lower alkyl or cycloalkyl having up to 8 carbon atoms and optionally substituted with alkyl having up to 4 carbon atoms, cycloalkyl having up to 6 carbon atoms or phenyl, with the proviso that when R is lower alkyl optionally substituted, R and X optionally unite together to make up a cycloaliphatic ring having from 5 to 7 carbon atoms; and acid addition salts thereof are prepared by reaction of a compound of Formula II with a compound of Formula IV and reducing the azomethinic compound in situ or by reaction of 3,3-diphenylpropionic acid with an amine of Formula V and reduction of the amide so formed or by reaction of a 3,3-diphenyl-1-halopropane with the above amine of Formula V The novel compounds have vasodilating activity.
GB2041575A 1974-05-15 1975-05-14 Cycloaliphatic derivatives of 3,3-diphenyl-propylamine Expired GB1461240A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2270974 1974-05-15

Publications (1)

Publication Number Publication Date
GB1461240A true GB1461240A (en) 1977-01-13

Family

ID=11199496

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2041575A Expired GB1461240A (en) 1974-05-15 1975-05-14 Cycloaliphatic derivatives of 3,3-diphenyl-propylamine

Country Status (4)

Country Link
JP (1) JPS5123248A (en)
DE (1) DE2521113A1 (en)
FR (1) FR2270853B1 (en)
GB (1) GB1461240A (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2482956A1 (en) * 1980-05-22 1981-11-27 Synthelabo Cardiovascular phenyl or cycloalkyl-cyclohexyl-alkylamine derivs. - which increase coronary flow but not cardiac work e.g. n-alpha-methyl-beta-phenyl:ethyl 2-cyclohexyl 2-phenyl ethylamine
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
AU2003250483A1 (en) 2002-08-19 2004-03-11 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
DE602004016123D1 (en) 2003-03-07 2008-10-09 Schering Corp SUBSTITUTED AZETIDINONE DERIVATIVES, THEIR PHARMACEUTICAL FORMULATIONS AND THEIR USE FOR THE TREATMENT OF HYPERCHOLESTEROLMIA
ATE418551T1 (en) 2003-03-07 2009-01-15 Schering Corp SUBSTITUTED AZETIDINONE DERIVATIVES, THEIR PHARMACEUTICAL FORMULATIONS AND THEIR USE IN THE TREATMENT OF HYPERCHOLESTEROLEMIA
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
JP5498168B2 (en) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー N-((3-Benzyl) -2,2- (bis-phenyl) -propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular disease
EA020466B1 (en) 2007-06-04 2014-11-28 Синерджи Фармасьютикалз Инк. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP2016516804A (en) 2013-04-17 2016-06-09 ファイザー・インク N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
CN113388007A (en) 2013-06-05 2021-09-14 博士医疗爱尔兰有限公司 Ultra-pure agonists of guanylate cyclase C, methods of making and using the same
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
JOP20210193A1 (en) 2019-01-18 2023-01-30 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof

Also Published As

Publication number Publication date
DE2521113A1 (en) 1976-03-18
FR2270853A1 (en) 1975-12-12
FR2270853B1 (en) 1978-09-08
JPS5123248A (en) 1976-02-24

Similar Documents

Publication Publication Date Title
GB1461240A (en) Cycloaliphatic derivatives of 3,3-diphenyl-propylamine
GB1345880A (en) Pyridazine derivatives
GB1325192A (en) Phloroglucinol derivatives
GB1468283A (en) N-1-omega-phenylalkyl-piperidyl-4-n-alpha-pyridyl-carbonic acid amides
GB1469307A (en) Manufacture of substituted oxazolinone-5-compounds
GB1262965A (en) Butyrophenones
GB1456627A (en) Pyridobenzodiazepinones
GB1471629A (en) Therapeutic compositions and methods
GB1053163A (en)
GB1474316A (en) O-aminoalkyl oximes
GB1478540A (en) 3-(2',3'-dihydroxypropyl) derivatives of hydantoin
ES454063A1 (en) Novel benzylalcohol derivatives and processes for preparing the same
GB1457038A (en) Amino derivatives of 1,4-benzodioxan
GB1505899A (en) 3,4-dihydrocarbostyril derivatives
GB1474896A (en) Salts of phenylpyridazines and the preparation thereof
GB1489803A (en) Aminoacetamides and a process for their preparation
ES438513A1 (en) Hexahydro-diazepino-indole derivatives
GB1514709A (en) Fungicidal thioamides
ES428673A1 (en) Substituted nitrobenzophenone derivatives
GB1359523A (en) Benzalacetone amidinohydrazone derivatives and the production thereof
SE7507318L (en) PROCEDURE FOR THE PRODUCTION OF AROMATIC URETANES.
GB1471901A (en) Styrylamidines
GB1528956A (en) Phenylalkanoic acid derivatives
GB1426310A (en) N-substituted cycloserine compounds
GB1450371A (en) Agents for eegulating plant growth

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee